Nuveen’s Assembly Biosciences ASMB Stock Holding History

Nuveen’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$464K	Buy	+16,875	New	+$459K	﹤0.01%	3311
2021 Q2	–	Sell	-17,630	Closed	-$973K	–	3363
2021 Q1	$973K	Sell	17,630 -95	-0.5%	-$6.3K	﹤0.01%	2890
2020 Q4	$1.29M	Sell	17,725 -9,398	-35%	-$1.1M	﹤0.01%	2712
2020 Q3	$5.35M	Sell	27,123 -8,687	-24%	-$2.19M	﹤0.01%	1880
2020 Q2	$10M	Sell	35,810 -5,999	-14%	-$1.4M	﹤0.01%	1487
2020 Q1	$7.44M	Buy	41,809 +12,449	+42%	+$2.67M	﹤0.01%	1478
2019 Q4	$7.21M	Buy	29,360 +11,305	+63%	+$2.08M	﹤0.01%	1786
2019 Q3	$2.13M	Sell	18,055 -4,684	-21%	-$709K	﹤0.01%	2367
2019 Q2	$3.68M	Buy	+22,739	New	+$4.32M	﹤0.01%	2152

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Nuveen's ASMB Position: Q2 2026 in Review

Nuveen opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 16,875 shares worth $464K. The stake represents ﹤0.01% of the portfolio and ranks #3311 among its holdings. This is a return to the name: Nuveen previously reported a position in ASMB as recently as Q1 2021.

Nuveen first reported a position in ASMB in Q2 2019 and has held it in 9 quarters since. The position peaked at $10M in Q2 2020. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Nuveen held 16,875 shares of Assembly Biosciences worth $464K as of Q2 2026.
Assembly Biosciences was a new Nuveen position in Q2 2026.
Assembly Biosciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3311 holding.
Nuveen first reported a position in Assembly Biosciences in Q2 2019 and has held it in 9 quarters since.
Nuveen's Assembly Biosciences position peaked at $10M in Q2 2020.
93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.